Welltower (NYSE:WELL) had its price target upped by research analysts at MED from $72.00 to $76.00 in a research report issued on Wednesday, The Fly reports. The brokerage currently has an “overweight” rating on the real estate investment trust’s stock. MED’s price target suggests a potential upside of 5.50% from the company’s previous close.
Several other research firms have also commented on WELL. ValuEngine upgraded Welltower from a “hold” rating to a “buy” rating in a research report on Wednesday, November 21st. Barclays initiated coverage on Welltower in a research report on Tuesday, September 25th. They issued an “overweight” rating for the company. Morgan Stanley lifted their price target on Welltower from $63.00 to $67.00 and gave the stock an “overweight” rating in a research report on Thursday, August 16th. SunTrust Banks lifted their price target on Welltower to $72.00 and gave the stock a “hold” rating in a research report on Wednesday, October 31st. Finally, TheStreet lowered Welltower from a “b” rating to a “c+” rating in a research report on Thursday, October 11th. Ten research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. The company currently has a consensus rating of “Hold” and an average price target of $64.50.
NYSE:WELL traded down $0.09 on Wednesday, reaching $72.04. 108,619 shares of the company’s stock traded hands, compared to its average volume of 1,781,903. The company has a quick ratio of 1.54, a current ratio of 1.54 and a debt-to-equity ratio of 0.93. The stock has a market cap of $27.10 billion, a PE ratio of 17.14, a P/E/G ratio of 3.02 and a beta of 0.26. Welltower has a 12 month low of $49.58 and a 12 month high of $73.88.
Welltower (NYSE:WELL) last posted its quarterly earnings results on Tuesday, October 30th. The real estate investment trust reported $0.17 EPS for the quarter, missing the Zacks’ consensus estimate of $1.02 by ($0.85). Welltower had a net margin of 12.99% and a return on equity of 4.86%. The business had revenue of $1.24 billion for the quarter, compared to the consensus estimate of $1.16 billion. During the same period in the prior year, the business earned $1.08 earnings per share. Welltower’s revenue was up 13.3% compared to the same quarter last year. Sell-side analysts anticipate that Welltower will post 4.05 earnings per share for the current fiscal year.
Several large investors have recently made changes to their positions in the business. Conning Inc. bought a new stake in shares of Welltower during the third quarter valued at approximately $478,000. Factory Mutual Insurance Co. raised its stake in shares of Welltower by 2.3% during the third quarter. Factory Mutual Insurance Co. now owns 559,500 shares of the real estate investment trust’s stock valued at $35,987,000 after acquiring an additional 12,500 shares in the last quarter. Sheets Smith Wealth Management bought a new stake in shares of Welltower during the third quarter valued at approximately $692,000. Shufro Rose & Co. LLC bought a new stake in shares of Welltower during the third quarter valued at approximately $11,539,000. Finally, Deroy & Devereaux Private Investment Counsel Inc. bought a new stake in shares of Welltower during the third quarter valued at approximately $15,716,000. Institutional investors and hedge funds own 88.54% of the company’s stock.
Welltower Company Profile
Welltower Inc (NYSE: WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.
Featured Story: Beta
Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.